Description: Shandong Shanda Wit Science and Technology Co., Ltd. engages in the pharmaceutical and environment protection businesses in China. Its medical products include azithromycin granules, glycyrrhiza zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gums, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company offers environmental products, including deep disc filters, sulfuric acid diluents, industrial wastewater treatment solutions, chlorine dioxide generators, chlorine dioxide purifiers, and flue gas desulfurization and denitrification emission technology, as well as plans and constructs artificial wetland. Its environmental products also comprise optional equipment and raw materials; chlorine dioxide disinfectants, compounds, and composites; waste gas treatment; and solid waste treatment. The company also provides information products, such as DLP splicing display units, LCD splicing display units, image stitching processors, industrial automation control products, and communication products; and crystal products. In addition, it is involved in the provision of education services. The company was founded in 1993 and is based in Jinan, China.
Home Page: www.sd-wit.com
Walter Plaza
Jinan,
250061
China
Phone:
86 53 1851 98090
Officers
| Name | Title |
|---|---|
| Ms. Jie Yang | MD & Director |
| Ms. Wei Wang | Financial Director |
| Mr. Da Yu Zhang | Deputy GM & Director |
| Mr. Zhisheng Fan | Sec. of the Board |
| Mr. Ning Fang | Deputy Gen. Mang. |
Exchange: SHE
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 20.0897 |
| Price-to-Book MRQ: | 3.7573 |
| Price-to-Sales TTM: | 4.7341 |
| IPO Date: | 1999-04-12 |
| Fiscal Year End: | December |
| Full Time Employees: | 2774 |